Dose-Response Association of Uncontrolled Blood Pressure and Cardiovascular Disease Risk Factors with Hyperuricemia and Gout

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Juraschek, Stephen P ^a,b   Kovell, Lara C ^c   Miller, Edgar R ^a,b,c   Gelber, Allan C ^a,b,c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; ANTIGOUT AGENT; CHOLESTEROL; COLCHICINE; DIURETIC AGENT; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; OXIPURINOL; PROBENECID; SULFINPYRAZONE; THIAZIDE DIURETIC AGENT; URIC ACID;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; GOUT; HUMAN; HYPERTENSION; HYPERURICEMIA; MAJOR CLINICAL STUDY; MALE; OBESITY; PREVALENCE; QUANTITATIVE ANALYSIS; SMOKING; SYSTOLIC BLOOD PRESSURE; UNITED STATES; URIC ACID BLOOD LEVEL;

ADULT; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLOMERULAR FILTRATION RATE; GOUT; HUMANS; HYPERURICEMIA; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; UNITED STATES; URIC ACID;

EID: 84874536864     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056546     Document Type: Article

References (42)

1. Choi HK, Mount DB, Reginato AM, (2005) Pathogenesis of gout. Ann Intern Med 143: 499-516.
2. Neogi T, (2011) Clinical practice. Gout. N Engl J Med 364: 443-52.
3. Kim KY, Schumacher H, Hunsche E, Wertheimer AI, Kong SX, (2003) A literature review of the epidemiology and treatment of acute gout. Clin Ther 25: 1593-617.
4. Anderson G, Horvath J, (2004) The growing burden of chronic disease in America. Public Health Rep 119: 263-70.
5. Ryu S, Chang Y, Zhang Y, Kim S-G, Cho J, et al. (2012) A cohort study of hyperuricemia in middle-aged South Korean men. Am J Epidemiol 175: 133-43.
6. Hochberg MC, Thomas J, Thomas DJ, Mead L, Levine DM, et al. (1995) Racial differences in the incidence of gout. The role of hypertension. Arthritis Rheum 38: 628-32.
7. Campion EW, Glynn RJ, DeLabry LO, (1987) Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study. Am J Med 82: 421-6.
8. McAdams-Demarco MA, Maynard JW, Baer AN, Coresh J, (2012) Hypertension and the risk of incident gout in a population-based study: the atherosclerosis risk in communities cohort. J Clin Hypertens (Greenwich) 14: 675-9.
9. Demarco MAM, Maynard JW, Baer AN, Gelber AC, Young JH, et al. (2012) Diuretic use, increased serum urate and the risk of incident gout in a population-based study of hypertensive adults: The atherosclerosis risk in the communities cohort. Arthritis and Rheumatism 64: 121-9.
10. Puig JG, Martínez MA, Mora M, Fraile JM, Montoya F, et al. (2008) Serum urate, metabolic syndrome, and cardiovascular risk factors. A population-based study. Nucleosides Nucleotides Nucleic Acids 27: 620-3.
11. Feig DI, Kang D-H, Johnson RJ, (2008) Uric acid and cardiovascular risk. N Engl J Med 359: 1811-21.
12. Choi HK, Ford ES, Li C, Curhan G, (2007) Prevalence of the metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey. Arthritis Rheum 57: 109-15.
13. Reaven GM, Hollenbeck C, Jeng CY, Wu MS, Chen YD, (1988) Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes 37: 1020-4.
14. Centers for Disease Control (1988). NHANES III- Reports and Reference Manuals. Available from: http://www.cdc.gov/nchs/nhanes/nh3rrm.htm. Accessed 22 November 2011.
15. Centers for Disease Control (1999). NHANES 1999-2010- Manuals, Brochures, and Consent Documents. Available from: http://www.cdc.gov/nchs/nhanes/. Accessed 22 November 2011.
16. Egan BM, Zhao Y, Axon RN, (2010) US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA 303: 2043-50.
17. National Heart Lung and Blood Institute (2004) The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Available: http://www.nhlbi.nih.gov/guidelines/hypertension/jnc7full.pdf. Accessed 30 October 2012.
18. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults, (1998) Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Am J Clin Nutr 68: 899-917.
19. World Health Organization (1995) WHO Expert Committee on Physical Status: The Use and Interpretation of Anthropometry. Available: https://apps.who.int/nut/publications.htm. Accessed 30 October 2012.
20. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604-12.
21. Selvin E, Manzi J, Stevens LA, Van Lente F, Lacher DA, et al. (2007) Calibration of serum creatinine in the National Health and Nutrition Examination Surveys (NHANES) 1988-1994, 1999-2004. Am J Kidney Dis 50: 918-26.
22. National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39(2 (Suppl 1): S1-266.
23. National Heart Lung and Blood Institute (2002) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Available: http://www.nhlbi.nih.gov/guidelines/cholesterol/. Accessed 30 October 2012.
24. Cowie CC, Rust KF, Byrd-Holt DD, Gregg EW, Ford ES, et al. (2010) Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988-2006. Diabetes Care 33: 562-8.
25. de Boer IH, Rue TC, Hall YN, Heagerty PJ, Weiss NS, et al. (2011) Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA. 2011 305: 2532-9.
26. American Diabetes Association, (2011) Diagnosis and classification of diabetes mellitus. Diabetes Care 34 (Suppl 1): S62-69.
27. Tsai J, Ford ES, Li C, Zhao G, (2012) Past and current alcohol consumption patterns and elevations in serum hepatic enzymes among US adults. Addict Behav 37: 78-84.
28. Greene HL, Wilson FA, Hefferan P, Terry AB, Moran JR, et al. (1978) ATP depletion, a possible role in the pathogenesis of hyperuricemia in glycogen storage disease type I. J Clin Invest. 62: 321-8.
29. Herman JB, Goldbourt U, (1982) Uric acid and diabetes: observations in a population study. Lancet 2: 240-3.
30. Boner G, Rieselbach RE, (1974) The effect of glucose upon reabsorptive transport of urate by the kidney. Adv Exp Med Biol 41: 781-7.
31. Rodríguez G, Soriano LC, Choi HK, (2010) Impact of diabetes against the future risk of developing gout. Ann Rheum Dis 69: 2090-4.
32. Yano K, Rhoads G, Kagan A, (1977) Epidemiology of serum uric acid among 8000 Japanese-American men in Hawaii. J Chronic Dis 30: 171-84.
33. Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, et al. (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120: 1640-5.
34. Forman JP, Choi H, Curhan GC, (2007) Plasma uric acid level and risk for incident hypertension among men. J Am Soc Nephrol 18: 287-92.
35. Mazzali M, Hughes J, Kim YG, Jefferson JA, Kang DH, et al. (2001) Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension 38: 1101-6.
36. Mellen PB, Bleyer AJ, Erlinger TP, Evans GW, Nieto FJ, et al. (2006) Serum uric acid predicts incident hypertension in a biethnic cohort: the atherosclerosis risk in communities study. Hypertension 48: 1037-42.
37. Perlstein TS, Gumieniak O, Williams GH, Sparrow D, Vokonas PS, et al. (2006) Uric acid and the development of hypertension: the normative aging study. Hypertension 48: 1031-6.
38. Centers for Disease Control (2008) National Ambulatory Medical Care Survey: 2008. Available: http://www.cdc.gov/nchs/fastats/docvisit.htm. Accessed 22 November 2011.
39. Klag MJ, Whelton PK, Appel LJ, (1990) Effect of age on the efficacy of blood pressure treatment strategies. Hypertension 16: 700-5.
40. Reyes AJ, (2003) Cardiovascular drugs and serum uric acid. Cardiovasc Drugs Ther 17: 397-414.
41. Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, et al. (1977) Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 20: 895-900.
42. McAdams MA, Maynard JW, Baer AN, Köttgen A, Clipp S, et al. (2011) Reliability and sensitivity of the self-report of physician-diagnosed gout in the campaign against cancer and heart disease and the atherosclerosis risk in the community cohorts. J Rheumatol 38: 135-41.